Introduction
The susceptibility of implanted biomaterials to bacterial attachment and biofilm formation, and thereby device-associated infections, is a serious problem in implant surgery. Most of the contaminating bacteria have been found to be coagulase-negative staphylococci [1] , which belong to the normal flora of human skin and mucous membranes [2] . These bacteria, of which Staphylococcus epidermidis is most frequently encountered in clinical situations, are a major cause of nosocomial infections typically found in patients with indwelling or implanted foreign polymer bodies.
The use of different kinds of bioabsorbable materials, especially in pediatric surgery, is increasing. Unfortunately, these materials are also prone to infection. In cases of vascular access, attempts have been made to prevent the attachment of bacteria by using various types of antibiotic coating systems [3] . Similarly, new bioabsorbable osteofixation devices, which can be manufactured in the form of screws that are osteoconductive, bioabsorbable, and antibioticreleasing, with reliable biomechanical properties [4, 5] , offer the possibility of combining antibiotics with them.
This in vitro study with scanning electron microscopy (SEM) was performed to evaluate whether bioabsorbable polylactide-co-glycolide (PLGA) 80/20 on its own, and PLGA together with ciprofloxacin (PLGA+AB) have any advantages over titanium in preventing S. epidermidis attachment and biofilm formation in culture media.
Materials and Methods
Biomaterials. Cylindrical specimens (7 mm long and 6.4 mm diameter) of bioabsorbable polymers were tested. They were made of either: 1) polylactide-co-glycolide (PLGA) 80/20, or 2) PLGA 80/20 containing ciprofloxacin. The cylinders were prepared at the Institute of Biomaterials, Tampere University of Technology, Tampere, Finland, and they were sterilized using gammairradiation. Titanium control cylinders of the same dimensions were prepared at KI-Technology Oy, Oulu, Finland, and gas-sterilized. Bacterial Strains. S. epidermidis ATCC 35989 was attached to the surface of the cylinders by incubation in glass tubes (one cylinder per tube) containing 4 ml of freshly prepared bacterial suspension (ca. 10 5 cfu/ml) in Trypticase soy broth (TSB) medium at 35 °C. As controls, similar cylinders were incubated in TSB medium without bacteria. After 1, 3, 7, 14 and 21 days, one specimen of each type of material was retrieved under aseptic conditions and prepared for scanning electron microscopy (SEM). The concentrations of the test bacteria in each tube were determined after each incubation period by quantitative plating on blood agar plates. The sensitivity of the test strain to ciprofloxacin was checked at the end of each incubation period. Each test was performed in triplicate. Scanning Electron Microscopy. For scanning electron microscopy (SEM), the cylinders were washed in phosphate buffer solution at pH 7.4 and fixed with 3% glutaraldehyde/phosphate buffer at pH 7.3 for 1.5 hours. After fixation, each specimen was washed three times in phosphate buffer and dehydrated with a series of increasing concentrations of ethanol. In absolute ethanol the samples were subjected to critical-point drying with carbon dioxide in a BAL-TEC CPD 030 critical point dryer (BAL-TEC Ltd., Balzers, Liechtenstein). The cylinders were then mounted on metal stubs with conductive carbon cement, coated with platinum-palladium in an Agar high resolution sputter coater (Agar Scientific Ltd., Stansted, UK) and examined by SEM (FESEM, JEOL JSM-6300F scanning electron microscope; JEOL LTD, Tokyo, Japan) at an accelerating voltage of 6kV. Standard examination fields were determined by SEM from the mechanically cut circular surface of cylindrical biomaterials and titanium specimens. At a magnification of ×3000 we proceeded by moving ½ mm at a time from the central point of the circular surface to the edge of the biomaterial along x and y axes in both directions. The presence or absence of bacteria and biofilm were documented in the examined areas (1.2×10 -3 mm 2 ). The number of bacterial cells present in each area was determined, and the amount of extracellular polymer material was estimated by using a scale of -(no biofilm formation), + (weak or moderate biofilm formation) and ++ (strong biofilm formation). Statistical Evaluation. For each material daily means of bacterial cell count were calculated for the 29 examined areas, taking into account only the non-zero values. The frequency of zeros (no bacterial cells) was recorded for each specimen. Since the data contained excess zeros, the analysis was carried out in two parts (two-part model): 1. The proportion of zeros was analyzed by the chisquare test or Fisher's exact test. 2. The non-zero part was analyzed by analysis of variance (ANOVA) or the non-parametric Kruskal-Wallis test. Two tailed p values are reported. Biofilm formation was analyzed by Fisher's exact test. The analyses were carried out using SPSS for Windows (version 11.5). Growth Inhibition Test on Agar Plates. Cylinders made of titanium, PLGA 80/20 and PLGA 80/20 containing ciprofloxacin were tested for their bacterial growth inhibitive properties by embedding one specimen of each in a blood agar plate containing S. epidermidis ATCC 35989 suspension at a concentration of ca. 10 7 cfu/ml in TSB medium. The plates were incubated overnight at 35 °C and the diameters of the inhibition areas were measured. Five parallel samples of each material were examined.
Results
PLGA containing ciprofloxacin inhibited bacterial growth on blood agar plates, showing an average diameter of growth inhibition area of 34 mm, while no inhibition was seen with pure PLGA and titanium specimens.
When the percentages of zero-findings (i.e. without S. epidermidis growth) were compared between the three materials at each time point (Table 1) , only 19.5% of the examined areas of the titanium specimens and 18.4% of PLGA specimens were negative on the first day, while the corresponding figure for ciprofloxacin-containing PLGA was 57.5%. On days 3 and 7 PLGA specimens were more often negative than the titanium ones. However, on days 14 and 21 the situation had changed, and titanium seemed to be slightly better than PLGA in preventing S. epidermidis growth. On the other hand, the proportion of zero findings was always clearly higher in
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Bioceramics 17 the ciprofloxacin-containing PLGA group. The zero findings in the three groups differed highly significantly at each time point, with p values of less or much less than 0.025. In the situations with S. epidermidis growth, the mean bacterial count in the titanium group was between those in the two PLGA groups. At each time point the PLGA group showed the highest growth and the ciprofloxacin-containing PLGA group the lowest S. epidermidis growth. During the whole study period apart from day 21, the means of bacterial growth differed statistically between the groups (Table 1) . The platings on blood agar of media from the incubation tubes contained no viable bacteria after each incubation period in the cases with ciprofloxacin-containing PLGA, while clear growth was observed in the culture media from tubes containing pure PLGA and titanium.
In the titanium group, no biofilm production was observed in most cases over a three-week period (74-93% of the cases). However, weak or moderate biofilm formation was seen in up to onefourth of the cases (7-24%) and even strong biofilm formation was occasionally observed. In harmony with the above-mentioned bacterial results, biofilm production was strongest in the PLGA group, in which bacteria were attached to the substratum by fibrous strands and were partially or entirely covered by extracellular polymer matrix (Figure 1 ). Weak or moderate biofilm formation was commonly seen in the PLGA group (20-41% of the examined areas of the specimens at different times). No biofilm was observed in the ciprofloxacin-releasing PLGA group on days 1 and 3. Biofilm production in this group was very slight over the entire study period and even when present, extracellular glycocalyx matrix occurred only slightly as amorphous material surrounding bacterial cells in some areas. Also biofilm production differed significantly between the three groups at each time point (p<0.001). 
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In conclusion, polylactide-co-glycolide (PLGA) ciprofloxacin-releasing material appeared to reduce staphylococcal attachment and biofilm formation significantly in vitro when compared with pure PLGA or titanium. This novel controlled drug delivery implant material may have a promising future with clinical applicability, for example, for prevention of infection in trauma surgery or in the treatment of chronic osteomyelitis.
